These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6331 related articles for article (PubMed ID: 3397991)

  • 1. Enantiomers of 7-(2,3-epoxypropoxy)actinomycin D as dual-action DNA-acting antitumor agents.
    Sengupta SK; Rosenbaum DP; Sehgal RK; Almassian B; Blondin J
    J Med Chem; 1988 Aug; 31(8):1540-7. PubMed ID: 3397991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbon-7 substituted actinomycin D analogues as improved antitumor agents: synthesis and DNA-binding and biological properties.
    Sengupta SK; Anderson JE; Kelley C
    J Med Chem; 1982 Oct; 25(10):1214-9. PubMed ID: 7143358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covalent binding of isomeric 7-(2,3-epoxypropoxy)actinomycin D to DNA.
    Sengupta SK; Blondin J; Szabo J
    J Med Chem; 1984 Nov; 27(11):1465-70. PubMed ID: 6492076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Reverse" and "symmetrical" analogues of actinomycin D: metabolic activation and in vitro and in vivo tumor growth inhibitory activities.
    Sengupta SK; Kelly C; Sehgal RK
    J Med Chem; 1985 May; 28(5):620-8. PubMed ID: 2985784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7-substituted actinomycin D analogs. Chemical and growth-inhibitory studies.
    Sengupta SK; Tinter SK; Lazarus H; Brown BL; Modest EJ
    J Med Chem; 1975 Dec; 18(12):1175-80. PubMed ID: 1059773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and some properties and antitumor effects of the actinomycin lactam analog, (di(1-L-alpha, beta-diaminopropionic))actinomycin D1.
    Moore S; Patel RP; Atherton E; Kondo M; Meienhofer J
    J Med Chem; 1976 Jun; 19(6):766-72. PubMed ID: 950643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N2- and C-7 substituted actinomycin D analogues: synthesis, DNA-binding affinity, and biochemical and biological properties. Structure-activity relationship.
    Sengupta SK; Anderson JE; Kogan Y; Trites DH; Beltz WR; Madhavarao MS
    J Med Chem; 1981 Sep; 24(9):1052-9. PubMed ID: 6169834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New actinomycin D analogues as superior chemotherapeutic agents against primary and advanced colon tumors and colon xenografts in nude mice.
    Sengupta SK; Kogan Y; Kelly C; Szabo J
    J Med Chem; 1988 Apr; 31(4):768-74. PubMed ID: 3351854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Deaminoactinomycin D, synthesis and interaction with deoxyribonucleic acid.
    Mosher CW; Kuhlmann KF; Kleid DG; Henry DW
    J Med Chem; 1977 Aug; 20(8):1055-9. PubMed ID: 330857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actinomycin D oxazinones as improved antitumor agents.
    Sengupta SK; Trites DH; Madhavarao MS; Beltz WR
    J Med Chem; 1979 Jul; 22(7):797-802. PubMed ID: 448678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antitumor activity of 2-deamino- and N2-(gamma-hydroxypropyl)actinomycin D.
    Moore S; Kondo M; Copeland M; Meienhofer J
    J Med Chem; 1975 Nov; 18(11):1098-101. PubMed ID: 809581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological properties of actinomycin D chromophoric analogues substituted at the 7-carbon with aziridine and aminopropoxy functions.
    Sehgal RK; Almassian B; Rosenbaum DP; Zadrozny R; Sengupta SK
    J Med Chem; 1987 Sep; 30(9):1626-31. PubMed ID: 3476754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological properties of N2-substituted spin-labeled analogues of actinomycin D.
    Sinha BK; Cox MG; Chignell CF; Cysyk RL
    J Med Chem; 1979 Sep; 22(9):1051-5. PubMed ID: 226705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of macromomycin B (NSC 170105) against murine leukemias, melanoma, and lung carcinoma.
    Lippman MM; Laster WR; Abbott BJ; Venditti J; Baratta M
    Cancer Res; 1975 Apr; 35(4):939-45. PubMed ID: 1116151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phenazine analogue of actinomycin D.
    Mosher CW; Lee DY; Enanoza RM; Sturm PA; Kuhlmann KF
    J Med Chem; 1979 Aug; 22(8):918-22. PubMed ID: 573799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineoplastic activity of didemnin congeners: nordidemnin and modified chain analogues.
    Jouin P; Poncet J; Dufour MN; Aumelas A; Pantaloni A; Cros S; François G
    J Med Chem; 1991 Feb; 34(2):486-91. PubMed ID: 1995869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N7-Substituted 7-aminoactinomycin D analogues. Synthesis and biological properties.
    Madhavarao MS; Chaykovsky M; Sengupta SK
    J Med Chem; 1978 Sep; 21(9):958-61. PubMed ID: 722760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new antitumor antibiotic, chounghwamycin A. I. Taxonomy, isolation and characterization.
    Liu YT; Ho TI; Lee AR; Chen CF; Chen HY; Chen CJ
    Proc Natl Sci Counc Repub China B; 1986 Apr; 10(2):98-104. PubMed ID: 2428073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of the anti-tumor effect of actinomycin D by tumor necrosis factor alpha in mice: correlation between in vitro and in vivo results.
    Lasek W; Giermasz A; Kuc K; Wańkowicz A; Feleszko W; Gołab J; Zagozdzon R; Stokłosa T; Jakóbisiak M
    Int J Cancer; 1996 May; 66(3):374-9. PubMed ID: 8621260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of mitoxantrone.
    White RJ; Durr FE
    Invest New Drugs; 1985; 3(2):85-93. PubMed ID: 2410393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 317.